Table 1 Sequences of primers used in this study.
Target RNA | Sequences | Direction | Product size (bp) |
|---|---|---|---|
Human MALAT1 | 5’-CTTCCCTAGGGGATTTCAGG-3’ | Forward | 76 |
5’-GCCCACAGGAACAAGTCCTA-3’ | Reverse | ||
Human NEAT1 | 5’-CTTCCTCCCTTTAACTTATCCATTCAC-3’ | Forward | 116 |
5’-CTCTTCCTCCACCATTACCAACAATAC-3’ | Reverse | ||
Human GAPDH | 5’-CGACCACTTTGTCAAGCTCA-3’ | Forward | 163 |
5’-CCCTGTTGCTGTAGCCAAAT-3’ | Reverse | ||
Murine Malat1 | 5’-TCTTCTATTCTTCGGCTTCCTACT-3’ | Forward | 66 |
5’-AAGCATCTTTAGAAGACAGAAAAG-3’ | Reverse | ||
Murine Neat1 | 5’-TGTTAAAGGCGCTTTGGAAG-3’ | Forward | 76 |
5’-GCGGGGCTAAGTATAAAGGAG-3’ | Reverse | ||
Murine Itgb2 | 5’-AGCAGAAGGACGGAAGGAACATTTAC-3’ | Forward | 136 |
5’-ATGACCAGGAGGAGGACACCAATC-3’ | Reverse | ||
Murine Klrd1 | 5’-AGCCTTCTTCAGCCCCAATC-3’ | Forward | 201 |
5’-AACGCTTTTGCTTGGACTGT-3’ | Reverse | ||
Murine Nkg2d | 5’-TGGCTTGCCATTTTCAAAGAGAC-3’ | Forward | 95 |
5’-TTAGGGCATGGGCCACAGTA-3’ | Reverse | ||
Murine Eat-2 | 5’-TTTGTTCCCCGCAGGCTTC-3’ | Forward | 146 |
5’-CGCATGGGACTCACAGAACT-3’ | Reverse | ||
Murine Gapdh | 5’-CTGGAGAAACCTGCCAAGTAT-3’ | Forward | 125 |
5’-GAGTTGCTGTTGAAGTCGCAG-3’ | Reverse |
